Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A. Cancer statistics, 2025. CA Cancer J Clin. 2025;75:10–45.
Google Scholar
Martinez-Outschoorn UE, Peiris-Pages M, Pestell RG, Sotgia F, Lisanti MP. Cancer metabolism: a therapeutic perspective. Nat Rev Clin Oncol. 2017;14:11–31.
Google Scholar
Pavlova NN, Zhu J, Thompson CB. The hallmarks of cancer metabolism: still emerging. Cell Metab. 2022;34:355–77.
Google Scholar
Bass J. Targeting time in metabolic therapeutics. Cell Metab. 2016;23:575–7.
Google Scholar
Suzuki T, Otsuka M, Seimiya T, Iwata T, Kishikawa T, Koike K. The biological role of metabolic reprogramming in pancreatic cancer. MedComm. 2020;1:302–10.
Google Scholar
De Santis MC, Bockorny B, Hirsch E, Cappello P, Martini M. Exploiting pancreatic cancer metabolism: challenges and opportunities. Trends Mol Med. 2024;30:592–604.
Google Scholar
Qin C, Yang G, Yang J, Ren B, Wang H, Chen G, et al. Metabolism of pancreatic cancer: paving the way to better anticancer strategies. Mol Cancer. 2020;19:50.
Google Scholar
Patra KC, Hay N. The pentose phosphate pathway and cancer. Trends Biochem Sci. 2014;39:347–54.
Google Scholar
Stincone A, Prigione A, Cramer T, Wamelink MM, Campbell K, Cheung E, et al. The return of metabolism: biochemistry and physiology of the pentose phosphate pathway. Biol Rev Camb Philos Soc. 2015;90:927–63.
Google Scholar
Liu H, Huang D, McArthur DL, Boros LG, Nissen N, Heaney AP. Fructose induces transketolase flux to promote pancreatic cancer growth. Cancer Res. 2010;70:6368–76.
Google Scholar
Vaziri-Gohar A, Cassel J, Mohammed FS, Zarei M, Hue JJ, Hajihassani O, et al. Limited nutrient availability in the tumor microenvironment renders pancreatic tumors sensitive to allosteric IDH1 inhibitors. Nat Cancer. 2022;3:852–65.
Google Scholar
Biancur DE, Paulo JA, Malachowska B, Quiles Del Rey M, Sousa CM, Wang X, et al. Compensatory metabolic networks in pancreatic cancers upon perturbation of glutamine metabolism. Nat Commun. 2017;8:15965.
Google Scholar
Son J, Lyssiotis CA, Ying H, Wang X, Hua S, Ligorio M, et al. Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway. Nature. 2013;496:101–5.
Google Scholar
Tsai PY, Lee MS, Jadhav U, Naqvi I, Madha S, Adler A, et al. Adaptation of pancreatic cancer cells to nutrient deprivation is reversible and requires glutamine synthetase stabilization by mTORC1. Proc Natl Acad Sci USA 2021;118:e2003014118.
Google Scholar
Deshpande GP, Patterton HG, Faadiel Essop M. The human transketolase-like proteins TKTL1 and TKTL2 are bona fide transketolases. BMC Struct Biol. 2019;19:2.
Google Scholar
Diaz-Moralli S, Aguilar E, Marin S, Coy JF, Dewerchin M, Antoniewicz MR, et al. A key role for transketolase-like 1 in tumor metabolic reprogramming. Oncotarget. 2016;7:51875–97.
Google Scholar
Coy JF, Dubel S, Kioschis P, Thomas K, Micklem G, Delius H, et al. Molecular cloning of tissue-specific transcripts of a transketolase-related gene: implications for the evolution of new vertebrate genes. Genomics. 1996;32:309–16.
Google Scholar
Fritz P, Coy JF, Murdter TE, Ott G, Alscher MD, Friedel G. TKTL-1 expression in lung cancer. Pathol Res Pr. 2012;208:203–9.
Google Scholar
Hu LH, Yang JH, Zhang DT, Zhang S, Wang L, Cai PC, et al. The TKTL1 gene influences total transketolase activity and cell proliferation in human colon cancer LoVo cells. Anticancer Drugs. 2007;18:427–33.
Google Scholar
Krockenberger M, Engel JB, Schmidt M, Kohrenhagen N, Hausler SF, Dombrowski Y, et al. Expression of transketolase-like 1 protein (TKTL1) in human endometrial cancer. Anticancer Res. 2010;30:1653–9.
Google Scholar
Langbein S, Frederiks WM, zur Hausen A, Popa J, Lehmann J, Weiss C, et al. Metastasis is promoted by a bioenergetic switch: new targets for progressive renal cell cancer. Int J Cancer. 2008;122:2422–8.
Google Scholar
Semilia M, Hennenlotter J, Pavone C, Bischoff T, Kuhs U, Gakis G, et al. Expression patterns and prognostic role of transketolase-like 1 in muscle-invasive bladder cancer. World J Urol. 2015;33:1403–9.
Google Scholar
Sun W, Liu Y, Glazer CA, Shao C, Bhan S, Demokan S, et al. TKTL1 is activated by promoter hypomethylation and contributes to head and neck squamous cell carcinoma carcinogenesis through increased aerobic glycolysis and HIF1alpha stabilization. Clin Cancer Res. 2010;16:857–66.
Google Scholar
Ahopelto K, Saukkonen K, Hagstrom J, Kauhanen S, Seppanen H, Bockelman C, et al. TKTL1 as a prognostic marker in pancreatic ductal adenocarcinoma and its correlation with FDG-PET-CT. Oncology. 2021;99:177–85.
Google Scholar
Hirayama A, Kami K, Sugimoto M, Sugawara M, Toki N, Onozuka H, et al. Quantitative metabolome profiling of colon and stomach cancer microenvironment by capillary electrophoresis time-of-flight mass spectrometry. Cancer Res. 2009;69:4918–25.
Google Scholar
Li Y, Yao CF, Xu FJ, Qu YY, Li JT, Lin Y, et al. APC/C(CDH1) synchronizes ribose-5-phosphate levels and DNA synthesis to cell cycle progression. Nat Commun. 2019;10:2502.
Google Scholar
Smeets EH, Muller H, de Wael J. A NADH-dependent transketolase assay in erythrocyte hemolysates. Clin Chim Acta. 1971;33:379–86.
Google Scholar
Han H, Cho JW, Lee S, Yun A, Kim H, Bae D, et al. TRRUST v2: an expanded reference database of human and mouse transcriptional regulatory interactions. Nucleic Acids Res. 2018;46:D380–6.
Google Scholar
Zhou Y, Zhou B, Pache L, Chang M, Khodabakhshi AH, Tanaseichuk O, et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun. 2019;10:1523.
Google Scholar
Bartha A, Gyorffy B. TNMplot.com: a web tool for the comparison of gene expression in normal, tumor and metastatic tissues. Int J Mol Sci. 2021;22:2622.
Google Scholar
Watanabe T, Seki T, Fukano T, Sakaue-Sawano A, Karasawa S, Kubota M, et al. Genetic visualization of protein interactions harnessing liquid phase transitions. Sci Rep. 2017;7:46380.
Google Scholar
Mauro C, Leow SC, Anso E, Rocha S, Thotakura AK, Tornatore L, et al. NF-kappaB controls energy homeostasis and metabolic adaptation by upregulating mitochondrial respiration. Nat Cell Biol. 2011;13:1272–9.
Google Scholar
Rayet B, Gelinas C. Aberrant rel/nfkb genes and activity in human cancer. Oncogene. 1999;18:6938–47.
Google Scholar
Franca GS, Yanai I. A mechanism for adaptive genome regulation in cancer. Nature. 2026;652:581–90.
Google Scholar
Hanahan D. Hallmarks of cancer-Then and now, and beyond. Cell. 2026;189:2254–77.
Google Scholar
Mora-Molina R, Fernandez-Farran FJ, Lopez-Rivas A, Palacios C. Activation of the integrated stress response and loss of cFLIP(L) under glutamine limitation induce IL-8 gene expression and secretion in glutamine-dependent tumor cells. Cell Death Discov. 2025;11:332.
Google Scholar
Kim SJ, Yoon S. Activated Rac1 regulates the degradation of IkappaBalpha and the nuclear translocation of STAT3-NFkappaB complexes in starved cancer cells. Exp Mol Med. 2016;48:e231.
Google Scholar
Morgan MJ, Liu ZG. Crosstalk of reactive oxygen species and NF-kappaB signaling. Cell Res. 2011;21:103–15.
Google Scholar
Nakajima S, Kitamura M. Bidirectional regulation of NF-kappaB by reactive oxygen species: a role of unfolded protein response. Free Radic Biol Med. 2013;65:162–74.
Google Scholar
Onodera T, Momose I, Adachi H, Yamazaki Y, Sawa R, Ohba SI, et al. Human pancreatic cancer cells under nutrient deprivation are vulnerable to redox system inhibition. J Biol Chem. 2020;295:16678–90.
Google Scholar
Djavaheri-Mergny M, Javelaud D, Wietzerbin J, Besancon F. NF-kappaB activation prevents apoptotic oxidative stress via an increase of both thioredoxin and MnSOD levels in TNFalpha-treated Ewing sarcoma cells. FEBS Lett. 2004;578:111–5.
Google Scholar
Kairisalo M, Korhonen L, Blomgren K, Lindholm D. X-linked inhibitor of apoptosis protein increases mitochondrial antioxidants through NF-kappaB activation. Biochem Biophys Res Commun. 2007;364:138–44.
Google Scholar
Commisso C, Davidson SM, Soydaner-Azeloglu RG, Parker SJ, Kamphorst JJ, Hackett S, et al. Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells. Nature. 2013;497:633–7.
Google Scholar
Altman BJ, Stine ZE, Dang CV. From Krebs to clinic: glutamine metabolism to cancer therapy. Nat Rev Cancer. 2016;16:619–34.
Google Scholar
Coy JF. EDIM-TKTL1/Apo10 blood test: an innate immune system-based liquid biopsy for the early detection, characterization and targeted treatment of cancer. Int J Mol Sci. 2017;18:878.
Google Scholar
Saman S, Stagno MJ, Warmann SW, Malek NP, Plentz RR, Schmid E. Biomarkers Apo10 and TKTL1: epitope-detection in monocytes (EDIM) as a new diagnostic approach for cholangiocellular, pancreatic and colorectal carcinoma. Cancer Biomark. 2020;27:129–37.
Google Scholar
Todenhofer T, Hennenlotter J, Keller G, Neumann T, Stenzl A, Bedke J. Effect of radical prostatectomy on levels of cancer-related epitopes in circulating macrophages of patients with clinically localized prostate cancer. Prostate. 2017;77:1251–8.
Google Scholar
